Skip to main content

Envestnet Asset Management Inc

Source: SEC Form 13F · as of Mar 2026

Envestnet Asset Management Inc holds 86 biotech & pharma companies tracked by BioSniper, totaling $1.04B in value as of Mar 2026 (SEC Form 13F).

Companies held

86

Total value held

$1.04B

BioSniper AIPage context preserved

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,859,012$259.1M
SNYSanofi3,861,894$186.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,837,744$101.4M
REGNREGENERON PHARMACEUTICALS, INC.109,152$84.3M
ALNYALNYLAM PHARMACEUTICALS, INC.171,797$56.8M
TEVATeva Pharmaceutical Industries Limited1,770,908$53.3M
INSMINSMED Inc299,925$49.0M
ARGXARGENX SE61,418$44.9M
GMABGenmab A/S862,301$23.1M
ROIVRoivant Sciences Ltd.678,518$18.8M
ONCBeOne Medicines Ltd.59,611$17.7M
JAZZJazz Pharmaceuticals plc89,311$16.9M
EXELEXELIXIS, INC.305,465$13.1M
VCELVericel Corp254,252$8.2M
BBIOBridgeBio Pharma, Inc.99,916$7.4M
IONSIONIS PHARMACEUTICALS INC93,382$7.0M
LGNDLigand Pharmaceuticals Incorporated34,576$6.9M
ABVXAbivax SA59,209$6.6M
INCYIncyte Corp.64,764$6.1M
PCVXVaxcyte, Inc.98,155$5.7M
AXSMAxsome Therapeutics, Inc.30,555$5.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.66,750$4.2M
ACADACADIA PHARMACEUTICALS INC169,954$3.8M
GRFSGrifols S.A.467,028$3.7M
TGTXTG THERAPEUTICS, INC.105,831$3.5M
DNTHDianthus Therapeutics, Inc. /DE/31,184$2.6M
COGTCogent Biosciences, Inc.62,230$2.4M
CYTKCYTOKINETICS INC34,537$2.3M
TERNTerns Pharmaceuticals, Inc.40,998$2.2M
VKTXViking Therapeutics, Inc.60,110$2.0M
MRNAModerna, Inc.38,290$1.9M
PTGXProtagonist Therapeutics, Inc16,317$1.7M
BMRNBIOMARIN PHARMACEUTICAL INC30,361$1.7M
IMCRImmunocore Holdings plc56,825$1.7M
NUVLNuvalent, Inc.15,810$1.6M
QUREuniQure N.V.96,559$1.6M
TVTXTravere Therapeutics, Inc.48,591$1.4M
NTLAIntellia Therapeutics, Inc.109,290$1.4M
ORKAOruka Therapeutics, Inc.23,667$1.2M
SUPNSUPERNUS PHARMACEUTICALS, INC.21,998$1.1M
ADMAADMA BIOLOGICS, INC.122,790$1.1M
ANIPANI PHARMACEUTICALS INC14,371$1.1M
CLDXCelldex Therapeutics, Inc.33,053$1.0M
ZYMEZymeworks Inc.40,419$1.0M
BEAMBeam Therapeutics Inc.42,194$1.0M
DNLIDenali Therapeutics Inc.50,900$977K
SRRKScholar Rock Holding Corp19,481$958K
CAPRCAPRICOR THERAPEUTICS, INC.29,316$891K
ADPTAdaptive Biotechnologies Corp61,948$860K
RVMDREVOLUTION MEDICINES, INC.8,820$858K
NKTRNEKTAR THERAPEUTICS10,883$783K
INVAInnoviva, Inc.32,470$757K
FBRXForte Biosciences, Inc.28,697$743K
RXRXRECURSION PHARMACEUTICALS, INC.230,112$706K
ARQTArcutis Biotherapeutics, Inc.28,908$681K
GPCRStructure Therapeutics Inc.11,377$548K
NAMSNEWAMSTERDAM PHARMA CO N.V.15,550$498K
SVRASavara Inc88,720$484K
BHVNBiohaven Ltd.57,065$483K
AGIOAGIOS PHARMACEUTICALS, INC.12,228$414K
AVXLANAVEX LIFE SCIENCES CORP.129,175$397K
ANABANAPTYSBIO, INC5,851$324K
VRDNViridian Therapeutics, Inc.\DE16,519$323K
HROWHARROW, INC.8,496$300K
AVTXAvalo Therapeutics, Inc.19,996$299K
EVOEvotec SE119,409$299K
APGEApogee Therapeutics, Inc.3,498$294K
CNTACentessa Pharmaceuticals plc6,975$277K
MDWDMediWound Ltd.16,539$266K
FLGTFulgent Genetics Inc.16,428$261K
SLNOSOLENO THERAPEUTICS INC7,693$258K
CHRSCoherus Oncology, Inc.152,194$257K
PVLAPALVELLA THERAPEUTICS, INC.1,853$231K
PTCTPTC THERAPEUTICS, INC.3,299$225K
PGENPRECIGEN, INC.49,341$191K
KURAKura Oncology, Inc.22,741$185K
ABSIAbsci Corporation57,284$172K
PBYIPUMA BIOTECHNOLOGY, INC.26,558$170K
IBRXImmunityBio, Inc.18,146$139K
OGNOrganon & Co.13,873$83K
SIGASIGA TECHNOLOGIES INC12,053$64K
ABEOABEONA THERAPEUTICS INC.13,291$60K
SLSSELLAS Life Sciences Group, Inc.10,941$46K
ABCLAbCellera Biologics Inc.12,716$44K
GERNGERON CORP18,188$27K
HRTXHERON THERAPEUTICS, INC. /DE/13,591$11K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.